| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.07 |
| 52 Week High | US$13.62 |
| 52 Week Low | US$8.74 |
| Beta | 1.13 |
| 1 Month Change | -2.21% |
| 3 Month Change | -13.65% |
| 1 Year Change | 19.03% |
| 3 Year Change | -28.58% |
| 5 Year Change | -43.66% |
| Change since IPO | 1,705.38% |
Recent News & Updates
Recent updates
Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.
Apr 24Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential
Apr 08Viatris Stock Is Still Worth Buying
Mar 30Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued
Mar 02From Euphoria To Reality: Viatris' Tale Of Market Whirlwind
Jan 12Viatris stock rises amid potential plans for €3B sale of European OTC assets
Oct 11Take These Broken Wings And Learn To Fly Again Viatris
Sep 25Viatris: 5% Dividend Yield Is A Threat For Investors
Sep 06Viatris: Products, Profitability And Pipeline - The Keys To Success
Aug 20Viatris declares $0.12 dividend
Aug 08Viatris: A Spinoff To Own
Aug 02Viatris extends decline to reach 52-week low
Jul 22Viatris: Guidance Likely To Be Cut With Q2 Results
Jul 15Viatris: The Market Is Not Buying It - Downtrend Since 2015
May 09Viatris: 3 Things That Can Break The Bull Thesis In 2022
Apr 20I No Longer Think Viatris Is A Buy
Apr 08Viatris: Takeaways From Management At The Raymond James Conference
Mar 10Shareholder Returns
| VTRS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -6.3% | 1.8% | 2.3% |
| 1Y | 19.0% | 16.0% | 26.8% |
Return vs Industry: VTRS exceeded the US Pharmaceuticals industry which returned 16% over the past year.
Return vs Market: VTRS underperformed the US Market which returned 26.8% over the past year.
Price Volatility
| VTRS volatility | |
|---|---|
| VTRS Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: VTRS has not had significant price volatility in the past 3 months.
Volatility Over Time: VTRS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 33,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VTRS fundamental statistics | |
|---|---|
| Market cap | US$13.26b |
| Earnings (TTM) | -US$56.10m |
| Revenue (TTM) | US$15.36b |
0.9x
P/S Ratio-235.0x
P/E RatioIs VTRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRS income statement (TTM) | |
|---|---|
| Revenue | US$15.36b |
| Cost of Revenue | US$8.68b |
| Gross Profit | US$6.68b |
| Other Expenses | US$6.73b |
| Earnings | -US$56.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.047 |
| Gross Margin | 43.47% |
| Net Profit Margin | -0.37% |
| Debt/Equity Ratio | 89.7% |
How did VTRS perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield-1,025%
Payout RatioDoes VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks| Viatris dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2024 |
| Dividend Pay Date | Jun 14 2024 |
| Days until Ex dividend | 7 days |
| Days until Dividend pay date | 29 days |
Does VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks